Applications are open for start-ups seeking grants from a $7.7 million fund offered by the NSW government to commercialise medical devices.
The NSW Medical Devices Fund receives $5 million a year from the state government.
Just over $10 million was committed to five projects in its first year, and $7.7 million is available for this round.
The applications will be assessed by the Medical Devices Fund Expert Group, which is chaired by Professor Mary O’Kane, who is an innovation consultant and the NSW Chief Scientist and Engineer.
The group also includes Cochlear chief financial officer Neville Mitchell, scientist and researcher Dr Bob Frater, investment banker Michael Still and broadcaster Adam Spencer.
In late 2013, the NSW Medical Devices Fund backed two start-ups, Elastagen and Endoluminal Sciences based at ATP Innovations, with $4.5 million combined.
ATP Innovations director of commercialisation Ben Wright told StartupSmart the fund was more likely to back more developed start-ups.
“They’re backing winners basically, who are going to make a big social impact and fully capable of taking these ideas all the way to market,” Wright said.
“They backed businesses that were well on their way already. They are going to market, and that’s the take home here,” Wright says. “These companies’ to-market timelines have certainly shifted thanks to this money.”
Applications close March 4.
Rose is the current head of growth at Rampersand Ventures. She was formerly a reporter at StartupSmart.
